» Articles » PMID: 39122502

Topical Corticophobia Among Healthcare Professionals in Saudi Arabia: A Cross-Sectional Study

Overview
Specialty Dermatology
Date 2024 Aug 9
PMID 39122502
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Corticophobia constitutes a complex challenge affecting patients and healthcare professionals alike, resulting in suboptimal management and treatment of dermatological conditions.

Objectives: This study aims to investigate corticophobia among physicians in Saudi Arabia and identify associated factors.

Methods: This is a retrospective, observational, cross-sectional study that included 700 participants. The sample constituted dermatologists, pediatricians, and family medicine practitioners at different levels (consultants, fellows, and residents) in Saudi Arabia. Data were collected via an electronic survey addressing demographic information and corticophobia-related questions.

Results: A total of 700 participants were included in the data analysis. Dermatologists were the most comfortable prescribing steroids (32%), followed by family medicine physicians (25%), and pediatricians (18%). Pediatricians were the most hesitant to prescribe steroids. Fellows were the most confident in prescribing steroids. Physicians from the northern and western regions were least likely to be hesitant in prescribing steroids.

Conclusions: In conclusion, this study reveals that in Saudi Arabia, dermatologists were the most comfortable prescribing topical corticosteroids, with pediatricians being the most hesitant. The findings emphasize the importance of education in addressing corticophobia among healthcare professionals, which could improve treatment adherence and patient outcomes. Further research and targeted educational interventions are necessary to enhance understanding and confidence in prescribing topical corticosteroids among healthcare professionals.

Citing Articles

Assessment and Knowledge of Long-Term Steroid Use and Its Related Cataract & Glaucoma Development Among Hail Residents.

Algorinees R, Alshammari B, Albalawi M, Almozaini K, Alharbi T, Alshammari T Clin Ophthalmol. 2025; 19:585-597.

PMID: 39990743 PMC: 11846618. DOI: 10.2147/OPTH.S510432.

References
1.
Aubert-Wastiaux H, Moret L, Le Rhun A, Fontenoy A, Nguyen J, Leux C . Topical corticosteroid phobia in atopic dermatitis: a study of its nature, origins and frequency. Br J Dermatol. 2011; 165(4):808-14. DOI: 10.1111/j.1365-2133.2011.10449.x. View

2.
Bos B, Antonescu I, Osinga H, Veenje S, de Jong K, De Vries T . Corticosteroid phobia (corticophobia) in parents of young children with atopic dermatitis and their health care providers. Pediatr Dermatol. 2018; 36(1):100-104. DOI: 10.1111/pde.13698. View

3.
Gustavsen H, Gjersvik P . Topical corticosteroid phobia among parents of children with atopic dermatitis in a semirural area of Norway. J Eur Acad Dermatol Venereol. 2014; 30(1):168. DOI: 10.1111/jdv.12670. View

4.
Dufresne H, Bataille P, Bellon N, Compain S, Deladriere E, Bekel L . Risk factors for corticophobia in atopic dermatitis. J Eur Acad Dermatol Venereol. 2020; 34(12):e846-e849. DOI: 10.1111/jdv.16739. View

5.
Lee J, Her Y, Kim C, Kim S . Topical Corticosteroid Phobia among Parents of Children with Atopic Eczema in Korea. Ann Dermatol. 2015; 27(5):499-506. PMC: 4622883. DOI: 10.5021/ad.2015.27.5.499. View